Does b12 deficiency lead to lack of treatment response to conventional antidepressants?

Psychiatry (Edgemont)

Volumn 7, Issue 11, 2010, Pages 42-44

  Kate, Natasha ^a   Sandeep, Grover ^a   Agarwal, Munish ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Depression; Treatment resistance; Vitamin b12 deficiency

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CYANOCOBALAMIN; ESCITALOPRAM; FLUOXETINE; FOLIC ACID; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CYANOCOBALAMIN DEFICIENCY; DOSE RESPONSE; DRUG DOSE INCREASE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; MEMORY DISORDER; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; PSYCHOMETRY; PSYCHOTHERAPY; SYMPTOMATOLOGY; TREATMENT DURATION; VEGETARIAN DIET; VITAMIN BLOOD LEVEL;

EID: 78650038775     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. O'Brien RF, Kifuji K, Summergrad P. Medical conditions with psychiatric manifestations. Adolesc Med. 2006;17:49-77
2. Iosifescu DV, Nierenberg AA, Alpert JE, et al. Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. 2004;45:419-425
3. Smith ADM. Megaloblastic madness. Br Med J. 1960;2:1840-1845
4. Fraser TN. Cerebral manifestations of Addisonian pernicious anaemia. Lancet. 1960;2:458-459
5. Strachan RW, Henderson JG. Psychiatric syndromes due to avitaminosis B12 with normal blood and marrow. Quart J Med 1965; 34:303-317